Letters of Interest

home


About EU-OPENSCREEN Concept ESFRI European Network Networks and Platforms Contact Preparatory Phase Project Work Packages Beneficiaries and Boards Letters of Interest Further Information News and Press Releases Events Scientific Conferences Scientific Articles Job Opportunities Links user pass Lost password?		Letters of Interest Below one can view the letters of interest that have been written in support of the EU-OPENSCREEN initiative (those marked with an asterisk () indicate a potential user of the infrastructure): Ministries / Funding Organisations* - Austria Austrian Federal Ministry of Science and Research (P. Kowalski) - Finland Finnish Ministry of Education (S. Karjalainen) - France Ministère de l'enseignement supérieur et de la recherche (D. Vandromme) - Germany Bundesministerium für Bildung und Forschung (P. Lange) Helmholtz-Association (J. Mlynek) Leibniz Association (E. Rietschel) Senatsverwaltung für Bildung, Wissenschaft und Forschung (J. Zöllner) - The Netherlands The Council for Chemical Sciences of the Netherlands Organization for Scientific Research (L. Vertegaal) - Norway Research Council of Norway (A. Hanneborg and A. Mo) - Poland Polish Ministry of Science and Higher Education (J. Szwed) - Spain Spanish Ministry of Science and Innovation (B. S. Gimeno) - Sweden Swedish Foundation for Strategic Research (L. Rask) Swedish Research Council (P. Omling) Initiatives / Infrastructures * Bio4IU (R. Di Lauro, recipient) Centre national de la recherche scientifique, Chemistry Institute (G. Chambaud) * ChemBioNet / European ScreeningPort (P. Gribbon) * EU-OPENSCREEN / European ScreeningPort (P. Gribbon) Fachsektion Chemische Biologie (J. Rademann and T. Mayer) * E-Rare (S. Koutouzov) * EATRIS (R. Balling) * EMBRC (R. Di Lauro) * Euro-BioImaging (G. Krestin and J. Ellenberg) INFRAFRONTIER (M. Hrabé de Angelis) * INSERM / LabEx (G. Kroemer and O. Kepp, recipients) * INSTRUCT (D. Stuart) * ISBE (R. Kitney) * MIRRI (D. Fritze) * Netherlands Cancer Institute, Dutch Compound Library (recipient) Oslo Cancer Cluster (T. Yrvum and J. Einarsson) * PharmaSea Consortium (M. Jaspars) * University of Aberdeen, BBSRC Diversity Oriented Biosynthesis (M. Jaspars) University of Oslo, MareLife (O. Lie) Companies AstraZeneca (B. Wallmark) Bayer Schering Pharma (H. Wild and E. Ottow) * Caprotec (H. Köster) GlaxoSmithKline (E. Diez) Inven2 (J. Dalland) Norwegian Bioindustry Association (T. Amlie) * Prestwick Chemical (T. Langer) Sanofi-Aventis (J. Maas and S. Krause) Institutes Broad Institute (J. Bittker) Centre national de la recherche scientifique, Institute of Biological Sciences (P. Netter) Ecole Polytechnique Fédérale de Lausanne (G. Turcatti) Fundación MEDINA (O. Genilloud) * Ghent University, Faculty of Bioscience Engineering (D. Geelen) * Griffith University, Eskitis Institute for Cell and Molecular Therapies (R. Quinn) * Griffith University, Queensland Compound Library (D. Camp) * KiWiZ (J. Imhoff) Lead Discovery Centre (B. Klebl) Max Planck Institute of Molecular Cell Biology and Genetics, HT-TDS (M. Bickle) Umeå University (M. Elofsson) * Universität Bonn (C. Müller) Universität Freiburg (M. Jung) * Albert-Ludwigs-Universität Freiburg (K. Palme, recipient) Universität Konstanz (T. Mayer) Universität Leipzig (T. Berg) Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz Screening Center (R. Stauber) * University of Naples Federico II (M. Santoro, recipient) * University of Rhode Island (K. Parang) University of Santiago de Compostela, USEF Screening Platform (M. Loza) Ghent University (D. Audenaert)